RICARDO A YARYURA

Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease SARASOTA, FL NPI 1083662266

General Payments — all program years on this page

$7,755.08

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 182
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $2,339.01 across 38 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $1,691.5835
Travel and Lodging $647.433

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $897.0719
2019 $680.6519
2020 $637.6223
2021 $1,241.6729
2022 $1,048.9726
2023 $910.0928
2024 $2,339.0138

Records — PY2024 (38)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1077977130 Janssen Pharmaceuticals, Inc $18.22 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087430148 Novartis Pharmaceuticals Corporation $18.19 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087430158 Novartis Pharmaceuticals Corporation $16.38 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087430162 Novartis Pharmaceuticals Corporation $23.34 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092444244 Boston Scientific Corporation $28.45 07/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092444246 Boston Scientific Corporation $46.25 03/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100410621 Impulse Dynamics (USA) Inc. $171.73 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116218202 Amgen Inc. $15.56 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116218207 Amgen Inc. $21.64 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116218212 Amgen Inc. $22.40 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117057219 Medtronic, Inc. $80.86 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124831677 Abbott Laboratories $23.98 03/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124831679 Abbott Laboratories $22.06 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124831681 Abbott Laboratories $135.75 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124831683 Abbott Laboratories $7.06 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124831685 Abbott Laboratories $23.78 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131030075 PFIZER INC. $15.66 02/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131172352 PFIZER INC. $18.27 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131464621 PFIZER INC. $13.10 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132319628 SCPHARMACEUTICALS INC. $16.89 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138813557 Edwards Lifesciences Corporation $71.76 01/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138813561 Edwards Lifesciences Corporation $52.42 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138813569 Edwards Lifesciences Corporation $106.26 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138813573 Edwards Lifesciences Corporation $38.00 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138813613 Edwards Lifesciences Corporation $25.24 05/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138813615 Edwards Lifesciences Corporation $173.19 05/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138813673 Edwards Lifesciences Corporation $98.70 08/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138813683 Edwards Lifesciences Corporation $31.33 08/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138813689 Edwards Lifesciences Corporation $60.99 08/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138813699 Edwards Lifesciences Corporation $30.10 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138813701 Edwards Lifesciences Corporation $192.85 09/11/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1138813703 Edwards Lifesciences Corporation $296.08 10/04/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1138813705 Edwards Lifesciences Corporation $70.53 10/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138813707 Edwards Lifesciences Corporation $71.24 10/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138813709 Edwards Lifesciences Corporation $67.81 10/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138813711 Edwards Lifesciences Corporation $158.50 12/05/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1151395187 Vasorum USA Inc. $35.33 01/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154890139 Kiniksa Pharmaceuticals International, plc $19.11 03/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.